Opaleye Management Inc. Acadia Pharmaceuticals Inc Transaction History

Opaleye Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $3.86 Million - $5.57 Million	217,000 New	217,000 $5.2 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $58,890 - $79,095	-1,500 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $6.49 Million - $9.61 Million	-205,000 Reduced 99.27%	1,500 $63,000
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $235,365 - $334,100	6,500 Added 3.25%	206,500 $8.83 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $80,850 - $136,900	5,000 Added 2.56%	200,000 $5.37 Million
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $2.54 Million - $4.25 Million	195,000 New	195,000 $4.05 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.